NVO vs. NVS
Compare and contrast key facts about Novo Nordisk A/S (NVO) and Novartis AG (NVS).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NVO or NVS.
Correlation
The correlation between NVO and NVS is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
NVO vs. NVS - Performance Comparison
Key characteristics
NVO:
-1.18
NVS:
1.29
NVO:
-1.72
NVS:
1.82
NVO:
0.77
NVS:
1.24
NVO:
-0.86
NVS:
1.16
NVO:
-1.74
NVS:
2.57
NVO:
26.39%
NVS:
9.02%
NVO:
38.77%
NVS:
17.92%
NVO:
-71.29%
NVS:
-41.72%
NVO:
-53.42%
NVS:
-3.80%
Fundamentals
NVO:
$309.27B
NVS:
$222.24B
NVO:
$3.29
NVS:
$5.88
NVO:
20.74
NVS:
18.84
NVO:
1.06
NVS:
1.29
NVO:
$225.05B
NVS:
$39.24B
NVO:
$190.45B
NVS:
$29.47B
NVO:
$113.24B
NVS:
$16.05B
Returns By Period
In the year-to-date period, NVO achieves a -20.74% return, which is significantly lower than NVS's 19.52% return. Over the past 10 years, NVO has outperformed NVS with an annualized return of 11.49%, while NVS has yielded a comparatively lower 7.10% annualized return.
NVO
-20.74%
-22.08%
-40.75%
-46.11%
19.54%
11.49%
NVS
19.52%
4.38%
2.23%
23.24%
11.72%
7.10%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
NVO vs. NVS — Risk-Adjusted Performance Rank
NVO
NVS
NVO vs. NVS - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (NVO) and Novartis AG (NVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
NVO vs. NVS - Dividend Comparison
NVO's dividend yield for the trailing twelve months is around 2.40%, less than NVS's 3.45% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NVO Novo Nordisk A/S | 2.40% | 1.68% | 1.00% | 1.20% | 1.34% | 1.86% | 2.14% | 2.47% | 2.12% | 3.93% | 1.31% | 1.96% |
NVS Novartis AG | 3.45% | 3.88% | 3.44% | 3.91% | 4.08% | 3.40% | 2.87% | 3.72% | 3.50% | 4.06% | 3.51% | 3.14% |
Drawdowns
NVO vs. NVS - Drawdown Comparison
The maximum NVO drawdown since its inception was -71.29%, which is greater than NVS's maximum drawdown of -41.72%. Use the drawdown chart below to compare losses from any high point for NVO and NVS. For additional features, visit the drawdowns tool.
Volatility
NVO vs. NVS - Volatility Comparison
Novo Nordisk A/S (NVO) has a higher volatility of 12.78% compared to Novartis AG (NVS) at 6.66%. This indicates that NVO's price experiences larger fluctuations and is considered to be riskier than NVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
NVO vs. NVS - Financials Comparison
This section allows you to compare key financial metrics between Novo Nordisk A/S and Novartis AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities